acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The situation with $AMBS has changed dramatically since January.
Lincoln Park Capital is investing almost $20,000,000 in the company and will be purchasing shares at the company's discretion and at no discount to the market. The company will have operating capital until 1H2016.
$AMBS is now six months closer to hitting the anticipated milestones that will be occurring in the coming weeks and months.
I expect the share price to hit .40 by the up-listing to the NASDAQ which I expect in an Oct./Nov. time frame.
The recent Chairman's blog does an excellent job of detailing what opportunities lay ahead for the company and its shareholders in both the short and long term.
"2H-2014: Milestones ahead to Position Amarantus for the Up-list"
http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/?utm_source=rss&utm_medium=rss&utm_campaign=2h-2014-milestones-ahead-position-amarantus-list
Many individuals under estimate the impact that the media coverage on LymPro will have on the share price.
Stay tuned for news. Exciting time to be an $AMBS shareholder.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. I still haven't found another micro-cap biotech that is trading at such a substantial discount to its potential value as is $AMBS at under eleven cents.
Immediate opportunity for LymPro:
322 Studies Currently for Drugs In Development for Alzheimer's:
http://clinicaltrials.gov/ct2/results?term=Alzheimer&recr=Open&no_unk=Y&pg=1
Within three years if it is not purchased by a "big pharma" drug company.
Great buy here for a retirement account.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Feel free to copy and paste the post anywhere you think it's appropriate so that others might find out about $AMBS.
The links provide them with the opportunity to obtain sufficient information to decide if they think $AMBS fits their investment criteria.
I just submitted a short article to SeekingAlpha about the company and its potential. If it's not accepted I'll post it in a blog on Monday with a link to it posted here and "tweeted" on Twitter: @wcoastguynca.
Have a great day!!!
Twitter: @AmarantusZBio .... 10,000+ followers.
First of all it's not sitting at a dime and secondly don't you have to actually own stock in the company to use the collective term "we".
Here's my latest post on one of the comments sections on Yahoo:
Sometimes the best opportunity for substantial profits is to invest in little known companies that have big potential before the market discovers them.
One of these companies is Amarantus Bioscience - AMBS- which is currently trading under 11 cents.
The company will be launching the first diagnostic blood test, LymPro, to detect early stage Alzheimer's this year. It's currently working with Becton Dickinson. The company is in the process of finalizing a partnership to market the test.
The recent Chairman's blog will give you a good overview of the company's potential with numerous other products in its pipeline and it discusses the planned up-listing to the NASDAQ this year:
http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/?utm_source=rss&utm_medium=rss&utm_campaign=2h-2014-milestones-ahead-position-amarantus-list
On Friday the company announced that it has entered into a research collaboration with the Washington University School of Medicine in St. Louis to evaluate the efficacy of the company's patented drug, MANF, to treat Wolfram-Syndrome in the field of diabetes.
http://finance.yahoo.com/news/amarantus-enters-wolframs-research-collaboration-132700921.html
Take the time to research the company before it's discovered by the market.
Twitter: @AmarantusBio .... 10,000+ followers.
What was the name of the company referenced and the name of the individual that posted that particular post three years ago?
How many companies has Lincoln Park Capital funded? 100's?
How many thousand's of individuals worked at these companies?
Ripoff Report Exposed: The Criminal Extortion SCAM by Ed Magedson
http://ripoffreportscam.wordpress.com/
It's always best to have both views presented.
Twitter: @AmarantusBio .... 10,000+ followers.
It obvious that the company will do a reverse split before the up-list to the NASDAQ. The sooner it happens the better.
I'm expecting the share price to be in the .35-.40 range when the reverse split actually happens which I expect will be in late October or early November. Share price in the $6.00 range afterwards works for me.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
The company is ready to sell shares to Lincoln Park Capital when Gerald decides to do so. It's great that the company has all the control.
"When I say buy, you ask how many shares."
Interesting weeks ahead.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
$500,000,000 market.
Gerald Commissiong ?@G_Commish 1h
We will give more in depth analysis in the near future, as additional data becomes available on MANF systemic delivery for diabetes.
Solantey ?
@G_Commish A "ball park" figure on potential revenues?
Gerald Commissiong ?@G_Commish 1h
@Solantey Based on our previous estimates, the worldwide market opportunity exceeds $500M and we believe the development timeline is reduced
Twitter: @AmarantusBio .... 10,000+ followers.
100% is more likely.
Stay tuned for news.
Twitter@AmarantusBio .... 10,000+ followers.
The market is just starting to discover the tremendous potential that the company has to offer.
It's a bargain here.
Twitter: @AmarantusBio .... 10,000+ followers.
Tweet from Gerald:
Solantey ?@Solantey 18m
@G_Commish Can you comment on the possibility that a major drug company such as Novartis may become involved with the Wolfram's research?
Gerald Commissiong ?@G_Commish 1m
@Solantey We will be attending BIO next week and have a full slate of meetings setup with various companies. I cannot comment on particulars.
Twitter: @AmarantusBio .... 10,000+ followers.
40-50% gain in six weeks. Jump on it.
Twitter: @AmarantusBio .... 10,000+ followers.
The one thing I'm certain of is that almost everyone on the board expects the share price to be at least 40-50% higher before August 1.
That is a virtual certainty.
The question is will you be happy with a 40-50% gain from today's price between now and August 1?
If not and you have better options in the market then I suggest you sell and move your funds to the other option.
Twitter: @AmarantusBio .... 10,000+ followers.
I'm still expecting .30 on August 1.
One p.r. doubles the share price.
Twitter: @AmarantusBio .... 10,000+ followers.
Stocks go up and stocks go down.
That is what makes a market.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. My time horizon is longer than a day.
"NUGT" is doing well.
Today's tweet from Gerald:
Solantey ?@Solantey
@G_Commish @The_Gr8Life
If certain milestones are accomplished is it possible a reverse split may not be required?
Gerald Commissiong ?@G_Commish
@Solantey @The_Gr8Life
certainly that is not off the table.
Thanks for the response.
Seems like there is a lot of scam companies working out of the Coral Gables, FL area.
Sometimes it pays to be optimistic.
p.s. "AMBS" under .12 and hold for six weeks.
Company's C.E.O. involved in another scam?
http://www.ag.nd.gov/NewsReleases/2012/06-21-12.pdf
Appears to be the same Chris Clarke. Anyone know otherwise?
.30 on August 1.
Lincoln Park Capital and Cavendish Global combined with milestones and catalysts will make it happen.
Up trend is in place.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. What is posted on the stock boards is irrelevant to this moving higher.
Catalysts for Amarantus Bioscience - $AMBS - Moving Higher
Today's Chairman's Blog
"2H-2014: Milestones ahead to Position Amarantus for the Up-list"
http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/?utm_source=rss&utm_medium=rss&utm_campaign=2h-2014-milestones-ahead-position-amarantus-list
.30 by August 1.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Lincoln Park Capital is investing $20,000,000 in $AMBS. Cavendish Global with access to $200B in investment capital is now a major supporter.
Bio International Convention - June 23-26 - San Diego
http://convention.bio.org/2014/
Amarantus Info:
http://mybio.org/exhibitor/member/81245 …
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Last day under .12
It will "never" be this cheap again.
News out soon.
Twitter: @AmarantusBio .... 10,000+ followers.
News tomorrow?
@G_Commish Updates will be out shortly. We are excited about the days, weeks, and months ahead. We are growing stronger by the day.
@fazoinnorcal *Shortly
— Gerald Commissiong (@G_Commish) June 17, 2014
Today "Notice of Effectiveness" means that the first tranche of shares are available for sale to Lincoln Park Capital (LPC) if and when Gerald decides to do so and at no discount to the market.
$AMBS's share price will continue to climb. LPC is committed to investing $20M with the tranches occurring at the time Gerald decides to sell the shares. The shares will be sold at no discount to the market. Considering the company's current cash on hand the first sale to LPC will occur when the share price is in the the .25-.30 range or higher. A number of expected milestones such as the news of a LymPro partnership which is expected at any time will take it there.
LPC knows that when it is announced that it has invested another $4-$5 million in $AMBS that the news will spike the share price especially as it will happen as milestones are achieved. Knowing that it will be purchasing shares at .25 it's obviously in LPC's best interest to purchase millions of cheap shares at the current low price and as it climbs towards the .25 range. It's one of the smartest investments that LPC can make currently. It's similar to you placing a bet on something for which you already know the outcome. When LPC made the decision to invest $20,000,000 in the company I can only imagine the due diligence that occurred to allow LPC to make the decision knowing they would be purchasing shares at no discount to the market. Obviously they had access to information that we don't have as retail investors.
Lincoln Park Capital will continue to buy to average down the share price of their future $AMBS share purchases.
Cavendish Global becoming a supporter with their associates having over $200B in investment capital will also contribute to the share price continued move higher.
The milestones and catalysts that will occur over the next weeks, months, and years make $AMBS the best investment opportunity in the market.
99% of the individuals that will own shares in $AMBS two years from now still haven't heard of the company or it's products. LymPro and MANF are about to change that.
Don't miss "buying" at the bottom. It isn't going lower.
"The next Amgen in it's infancy."
Twitter: @AmarantusBio .... 10,000 followers
p.s. Overdue for major news.
@G_Commish Updates will be out shortly. We are excited about the days, weeks, and months ahead. We are growing stronger by the day.
@fazoinnorcal *Shortly
— Gerald Commissiong (@G_Commish) June 17, 2014
There is no way LPC would let the share price go from .187 back to .11 with the up-listing nearing and milestones ahead.
Anyone who sells at .187 thinking they'll buy back at at .11 is going to be left on the sidelines.
How about the scenario where you sell at .187 and re-buy at .30.
Thanks for the humorous post. I'm still chuckling.
Twitter: @AmarantusBio .... 10,000+ followers.
"little while longer"?
I don't consider years to be a little while longer.
$AMBS - "The next Amgen in its infancy."
Twitter: @AmarantusBio .... 10,000+ followers.
Today's tweet from Gerald:
@G_Commish Updates will be out shortly. We are excited about the days, weeks, and months ahead. We are growing stronger by the day.
Twitter: @AmarantusBio .... 10,000+ followers.
Some individuals still don't get it.
This will be above .25 by July 15.
Cheap shares are being acquired.
Whether the next news is a press release or a Chairman's blog is irrelevant.
Enjoy the ride or sell shares tomorrow. That is what makes a market.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000 followers.
Why $AMBS's Share Price Is Going Much Higher
$AMBS's share price will continue to climb. Lincoln Park Capital (LPC) is committed to investing $20M with the tranches occurring at the time Gerald decides to sell the shares. The shares will be sold at no discount to the market. Considering the company's current cash on hand the first sale to LPC will occur when the share price is in the the .25-.30 range or higher. A number of expected milestones such as the news of a LymPro partnership which is expected at any time will take it there.
LPC knows that when it is announced that it has invested another $4-$5 million in $AMBS that the news will spike the share price especially as it will happen as milestones are achieved. Knowing that it will be purchasing shares at .25 it's obviously in LPC's best interest to purchase millions of cheap shares at the current low price and as it climbs towards the .25 range. It's one of the smartest investments that LPC can make currently. It's similar to you placing a bet on something for which you already know the outcome. When LPC made the decision to invest $20,000,000 in the company I can only imagine the due diligence that occurred to allow LPC to make the decision knowing they would be purchasing shares at no discount to the market. Obviously they had access to information that we don't have as retail investors.
Lincoln Park Capital will continue to buy to average down the share price of their future $AMBS share purchases.
Cavendish Global becoming a supporter with their associates having over $200B in investment capital will also contribute to the share price continued move higher.
The milestones and catalysts that will occur over the next weeks, months, and years make $AMBS the best investment opportunity in the market.
99% of the individuals that will own shares in $AMBS two years from now still haven't heard of the company or it's products. LymPro and MANF are about to change that.
Don't miss "buying" at the bottom. It isn't going lower.
"The next Amgen in it's infancy."
Twitter: @AmarantusBio .... 10,000 followers
p.s. Overdue for major news.
Lincoln Park Capital has control and LPC is stealing shares from the shorts and from the longs not smart enough to realize that it's not going lower.
Who has better information? Someone posting on the stock boards or LPC who is investing $20,000,000 buying shares at the company's discretion and at no discount to the market?
Stay tuned for LymPro partnership news and other milestones.
Twitter: @AmarantusBio .... 10,000 followers.
p.s. LPC best investment opportunity is buying cheap $AMBS shares knowing they'll be paying more for future shares. Best way to cost average down.
Guesses are free.
I'm guessing .25 or higher on July 15.
Here's why:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=103295705
Overdue for a Chairman's blog.
Twitter: @AmarantusBio .... 10,000 followers.
Without news I think it could retest $4.35 or much lower with an overall market correction.
Hoping for a new Chairman's blog soon.
Solantey ?@Solantey
@FumihikoUrano Meeting with @G_Commish from @AmarantusBio ?
Gerald Commissiong ?@G_Commish
@Solantey @FumihikoUrano @AmarantusBio Yes. Excellent meeting this morning with Fumi and the Snow Foundation. Great group
Twitter: @AmarantusBio .... 10,000 followers.
My initial research points to CYBK being a scam.
It appears that the company's C.E.O., Chris Clarke, has been associated with other scams in the past.
Is there any reason I should believe that it isn't a scam?
A link to any information would be helpful.
Great chart.
Breaking through to .25 and beyond.
The "fact" is that I think $AMBS is substantially undervalued currently and I also think that as the anticipated milestones are hit that the share price will move substantially higher.
Obviously if I thought I was "pushing too much" I wouldn't.
Many said the same thing when the share price was below a nickle and I think they'll be many who will say it when the share price is above a $1.00.
Over the next days, weeks, and months it will become obvious as to whether or not my optimism was warranted.
Expecting news soon which will contribute to my optimism.
Obviously Lincoln Park Capital and Cavendish Global share my enthusiasm. Especially LPC to the tune of $20,000,000.
Twitter: @AmarantusBio .... 10,000 followers.